Literature DB >> 20187256

The biology and pathology of the familial Parkinson's disease protein LRRK2.

William Dauer1, Cherry Cheng-Ying Ho.   

Abstract

Parkinson's disease (PD) is typically a sporadic illness, but the past decade has witnessed the identification of mutations responsible for multiple familial forms of the disease. The proposed functions of some of these genes (e.g., E3 ubiquitin ligase, redox-dependent chaperone) have led to the hypothesis that dysfunction of protein quality control pathways contributes to PD neurodegeneration. However, the key signaling events that act downstream of misfolded proteins to cause cell death remain poorly defined. The discovery of the familial PD kinase leucine-rich repeat kinase 2 (LRRK2) holds great promise for the elucidation of signaling events relevant to PD neurodegeneration. This review will summarize current knowledge of the clinical and cell biological features of LRRK2, the most common inherited cause of Parkinsonism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187256     DOI: 10.1002/mds.22717

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  11 in total

Review 1.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

Review 2.  Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.

Authors:  Fernando Calahorro; Manuel Ruiz-Rubio
Journal:  Invert Neurosci       Date:  2011-11-08

3.  LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease.

Authors:  Rachel Saunders-Pullman; Matthew J Barrett; Kaili M Stanley; Marta San Luciano; Vicki Shanker; Lawrence Severt; Ann Hunt; Deborah Raymond; Laurie J Ozelius; Susan B Bressman
Journal:  Mov Disord       Date:  2010-11-15       Impact factor: 10.338

Review 4.  Genetic analysis of pathways to Parkinson disease.

Authors:  John Hardy
Journal:  Neuron       Date:  2010-10-21       Impact factor: 17.173

5.  Inhibitors of LRRK2 kinase attenuate neurodegeneration and Parkinson-like phenotypes in Caenorhabditis elegans and Drosophila Parkinson's disease models.

Authors:  Zhaohui Liu; Shusei Hamamichi; Byoung Dae Lee; Dejun Yang; Arpita Ray; Guy A Caldwell; Kim A Caldwell; Ted M Dawson; Wanli W Smith; Valina L Dawson
Journal:  Hum Mol Genet       Date:  2011-07-18       Impact factor: 5.121

6.  Dysregulated LRRK2 signaling in response to endoplasmic reticulum stress leads to dopaminergic neuron degeneration in C. elegans.

Authors:  Yiyuan Yuan; Pengxiu Cao; Mark A Smith; Kristopher Kramp; Ying Huang; Naoki Hisamoto; Kunihiro Matsumoto; Maria Hatzoglou; Hui Jin; Zhaoyang Feng
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

Review 7.  Genetics of Parkinson's disease - a clinical perspective.

Authors:  Sang-Myung Cheon; Lilian Chan; Daniel Kam Yin Chan; Jae Woo Kim
Journal:  J Mov Disord       Date:  2012-10-30

8.  Predictive Big Data Analytics: A Study of Parkinson's Disease Using Large, Complex, Heterogeneous, Incongruent, Multi-Source and Incomplete Observations.

Authors:  Ivo D Dinov; Ben Heavner; Ming Tang; Gustavo Glusman; Kyle Chard; Mike Darcy; Ravi Madduri; Judy Pa; Cathie Spino; Carl Kesselman; Ian Foster; Eric W Deutsch; Nathan D Price; John D Van Horn; Joseph Ames; Kristi Clark; Leroy Hood; Benjamin M Hampstead; William Dauer; Arthur W Toga
Journal:  PLoS One       Date:  2016-08-05       Impact factor: 3.240

Review 9.  Mechanisms of aging-related proteinopathies in Caenorhabditis elegans.

Authors:  Dong-Kyu Kim; Tae Ho Kim; Seung-Jae Lee
Journal:  Exp Mol Med       Date:  2016-10-07       Impact factor: 8.718

10.  Distinctive roles of Rac1 and Rab29 in LRRK2 mediated membrane trafficking and neurite outgrowth.

Authors:  Min Feng; Xin Hu; Na Li; Fan Hu; Fei Chang; Hong-Fei Xu; Yong-Jian Liu
Journal:  J Biomed Res       Date:  2018-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.